Minister of Public Services and Procurement Anita Anand announced on Tuesday that the government has signed new agreements with Gilead Sciences and McKesson Canada to secure supply of up to 150,000 vials of the drug Remdesivir. Remdesivir, an experimental anti-viral drug, has shown signs in clinical trials that it could help COVID-19 patients.
Canada
Coronavirus: Canada secures 150,000 vials of Remdesivir with Gilead Sciences, McKesson Canada
More Videos
-
Stanley Cup playoffs: Are the Edmonton Oilers really Canada’s team?
-
Toronto officially receiving WNBA team in 2026
-
Canada restoring citizenship to ‘lost Canadians’
-
Canada, U.S. to see ‘extraordinary’ hurricane season, NOAA predicts
-
Canada, U.S. to see above-normal Atlantic hurricane season, officials stress to ‘be prepared’
-
Liberals, Conservatives trade allegations of corruption: ‘Lining her own pockets’
You are viewing an Accelerated Mobile Webpage.
View Original Article